✦ LIBER ✦

Structure-based optimization of morpholino-triazines as PI3K and mTOR inhibitors

✍ Scribed by Anders Poulsen; Meredith Williams; Harish Mysore Nagaraj; Anthony D. William; Haishan Wang; Chang Kai Soh; Zheng Chang Xiong; Brian Dymock

Book ID: 113496457
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 781 KB
Volume: 22
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2011.12.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of novel morpholino–quinoxalin

Discovery of novel morpholino–quinoxalines as PI3Kα inhibitors by pharmacophore-based screening

✍ Wu, Peng; Su, Yi; Liu, Xiaowen; Yan, Jingying; Ye, Yong; Zhang, Lei; Xu, Jiancha 📂 Article 📅 2012 🏛 The Royal Society of Chemistry 🌐 English ⚖ 349 KB

Identification of 2-oxatriazines as high

Identification of 2-oxatriazines as highly potent pan-PI3K/mTOR dual inhibitors

✍ Christoph M. Dehnhardt; Aranapakam M. Venkatesan; Zecheng Chen; Efren Delos-Sant 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 561 KB

SP 114 Predictive and pharmacodynamic (P

SP 114 Predictive and pharmacodynamic (PD) markers of PI3K pathway inhibitors: focus on PI3K, AKT and mTOR inhibitors

✍ J. Tabernero 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Discovery of the highly potent PI3K/mTOR

Discovery of the highly potent PI3K/mTOR dual inhibitor PF-04691502 through structure based drug design

✍ Cheng, Hengmiao; Bagrodia, Shubha; Bailey, Simon; Edwards, Martin; Hoffman, Jacq 📂 Article 📅 2010 🏛 The Royal Society of Chemistry 🌐 English ⚖ 274 KB

Structure-based optimization of pyrazolo

Structure-based optimization of pyrazolo-pyrimidine and -pyridine inhibitors of PI3-kinase

✍ Steven T. Staben; Timothy P. Heffron; Daniel P. Sutherlin; Seema R. Bhat; George 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 1007 KB

## a b s t r a c t Starting from HTS hit 1a, X-ray co-crystallization and molecular modeling were used to design potent and selective inhibitors of PI3-kinase. Bioavailablity in this series was improved through careful modulation of physicochemical properties. Compound 12 displayed in vivo knockdo

The PI3K/AKT/MTOR Signaling Pathway: The

The PI3K/AKT/MTOR Signaling Pathway: The Role of PI3K and AKT Inhibitors in Breast Cancer

✍ Huemer, Florian; Bartsch, Rupert; Gnant, Michael 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 355 KB